BRPI0911907A2 - Mistura de triptofano ligado a peptídeo e de triptofano ligado a polipeptídeo - Google Patents

Mistura de triptofano ligado a peptídeo e de triptofano ligado a polipeptídeo

Info

Publication number
BRPI0911907A2
BRPI0911907A2 BRPI0911907-8A BRPI0911907A BRPI0911907A2 BR PI0911907 A2 BRPI0911907 A2 BR PI0911907A2 BR PI0911907 A BRPI0911907 A BR PI0911907A BR PI0911907 A2 BRPI0911907 A2 BR PI0911907A2
Authority
BR
Brazil
Prior art keywords
tryptophan
polypeptide
peptide
mixture
linked
Prior art date
Application number
BRPI0911907-8A
Other languages
English (en)
Inventor
Cinderella Christina Gerhardt
Luppo Edens
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0911907A2 publication Critical patent/BRPI0911907A2/pt
Publication of BRPI0911907B1 publication Critical patent/BRPI0911907B1/pt
Publication of BRPI0911907B8 publication Critical patent/BRPI0911907B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/08Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from eggs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/22Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0911907A 2008-04-29 2009-04-27 processo para produzir uma composição contendo triptofano e composição proteica contendo triptofano BRPI0911907B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08155315 2008-04-29
EP08155315.8 2008-04-29
PCT/EP2009/055038 WO2009133055A1 (en) 2008-04-29 2009-04-27 Mixture of peptide-bound tryptophan and polypeptide-bound tryptophan

Publications (3)

Publication Number Publication Date
BRPI0911907A2 true BRPI0911907A2 (pt) 2015-07-28
BRPI0911907B1 BRPI0911907B1 (pt) 2021-02-02
BRPI0911907B8 BRPI0911907B8 (pt) 2021-05-25

Family

ID=39811461

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911907A BRPI0911907B8 (pt) 2008-04-29 2009-04-27 processo para produzir uma composição contendo triptofano e composição proteica contendo triptofano

Country Status (10)

Country Link
US (2) US8802088B2 (pt)
EP (1) EP2268157B1 (pt)
JP (1) JP5626807B2 (pt)
KR (1) KR101698216B1 (pt)
CN (1) CN102076228B (pt)
BR (1) BRPI0911907B8 (pt)
EA (2) EA029869B1 (pt)
ES (1) ES2550463T3 (pt)
PL (1) PL2268157T3 (pt)
WO (1) WO2009133055A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2382910T3 (es) 2006-11-02 2012-06-14 Dsm Ip Assets B.V. Uso de hidrolizados de lisozima que contienen triptófano
CN102076222B (zh) * 2008-04-29 2014-04-09 帝斯曼知识产权资产管理有限公司 包含碳水化合物和含色氨酸的肽的组合物
KR101698216B1 (ko) * 2008-04-29 2017-01-19 디에스엠 아이피 어셋츠 비.브이. 펩타이드-결합된 트립토판과 폴리펩타이드-결합된 트립토판의 혼합물
CN103153326B (zh) * 2010-10-05 2015-08-19 帝斯曼知识产权资产管理有限公司 含有色氨酸的肽
PL2701716T3 (pl) 2011-04-28 2018-02-28 Dsm Ip Assets B.V. Hydrolizaty białkowe jako środki do przezwyciężania uzależnień
US10194674B2 (en) 2011-09-01 2019-02-05 John C. Gilkey Nutritional compositions
JP2013159591A (ja) * 2012-02-08 2013-08-19 Morinaga Milk Ind Co Ltd 多動性抑制剤
CN104334037B (zh) * 2012-11-02 2019-02-22 帝斯曼知识产权资产管理有限公司 富含色氨酸的蛋白水解产物的用途
EP3082837B1 (en) * 2013-12-18 2020-09-09 DSM IP Assets B.V. Compositions comprising lysozyme hydrolysate for use in keratin-containing tissue
CA2995395C (en) * 2015-08-31 2024-04-16 Nutramax Laboratories, Inc. Compositions comprising magnolia, phellodendron, theanine and/or whey protein
US10591221B1 (en) 2017-04-04 2020-03-17 Mainstream Engineering Corporation Advanced cooling system using throttled internal cooling passage flow for a window assembly, and methods of fabrication and use thereof
JP7139727B2 (ja) * 2018-06-29 2022-09-21 キリンホールディングス株式会社 運動制御機能および運動学習機能向上用組成物
NL2022627B1 (en) 2019-02-22 2020-08-31 Newtricious Bv Lysozyme hydrolysate for proactive inhibitory control and for attention
JP7428480B2 (ja) * 2019-06-06 2024-02-06 雪印メグミルク株式会社 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料
CA3212435A1 (en) * 2021-03-15 2022-09-22 Lara Nyman Nutritional composition for improving sleep
WO2024204250A1 (ja) * 2023-03-29 2024-10-03 株式会社明治 ドーパミン放出量増強剤、運動制御機能改善剤、運動学習機能改善剤及び活動意欲改善剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02279700A (ja) * 1989-04-19 1990-11-15 Asahi Chem Ind Co Ltd 高トリプトファン含有ペプチド
FR2657013B1 (fr) * 1990-01-18 1992-05-15 Medgenix Group Sa Composition dietetique a base de polypeptides et acides amines.
KR100796853B1 (ko) * 2000-12-06 2008-01-22 캄피나 쥐벨 베.붸. 과량 트립토판 함유 펩티드의 제조방법
JP4221231B2 (ja) 2002-02-28 2009-02-12 株式会社ファーマフーズ 抗菌組成物、その製造方法及び該抗菌組成物を含有する抗菌剤
CN1968691B (zh) 2004-04-19 2010-12-29 麒麟麦酒株式会社 用于通过葡糖异生作用加速酒精代谢或从疲劳恢复的组合物
CN101022737B (zh) 2004-07-22 2012-08-15 格罗伯斯卵类科学有限公司 抗高血压的功能性食品
EP1685764A1 (en) * 2005-01-27 2006-08-02 Globus Egg Sciences B.V. Anti-hypertensive functional food products
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
ES2382910T3 (es) * 2006-11-02 2012-06-14 Dsm Ip Assets B.V. Uso de hidrolizados de lisozima que contienen triptófano
KR101698216B1 (ko) * 2008-04-29 2017-01-19 디에스엠 아이피 어셋츠 비.브이. 펩타이드-결합된 트립토판과 폴리펩타이드-결합된 트립토판의 혼합물
CN102076222B (zh) * 2008-04-29 2014-04-09 帝斯曼知识产权资产管理有限公司 包含碳水化合物和含色氨酸的肽的组合物

Also Published As

Publication number Publication date
KR101698216B1 (ko) 2017-01-19
WO2009133055A1 (en) 2009-11-05
US9770493B2 (en) 2017-09-26
EA201001711A1 (ru) 2011-06-30
PL2268157T3 (pl) 2015-12-31
JP5626807B2 (ja) 2014-11-19
US20150037313A1 (en) 2015-02-05
US20110110919A1 (en) 2011-05-12
US8802088B2 (en) 2014-08-12
CN102076228A (zh) 2011-05-25
BRPI0911907B8 (pt) 2021-05-25
EA029869B1 (ru) 2018-05-31
BRPI0911907B1 (pt) 2021-02-02
EP2268157B1 (en) 2015-08-19
EP2268157A1 (en) 2011-01-05
KR20100135319A (ko) 2010-12-24
ES2550463T3 (es) 2015-11-10
JP2011523547A (ja) 2011-08-18
EA201400526A1 (ru) 2014-12-30
EA021506B1 (ru) 2015-07-30
CN102076228B (zh) 2016-08-03

Similar Documents

Publication Publication Date Title
BRPI0911907A2 (pt) Mistura de triptofano ligado a peptídeo e de triptofano ligado a polipeptídeo
EP2298731A4 (en) AMIDE COMPOUND
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
SG10201400162QA (en) Tgr5 modulators and methods of use thereof
DK2349430T3 (da) KATETERISERINGANORDNING og -kit
ZA201104463B (en) Compounds and methods of use
BRPI0916735A2 (pt) moduladores de tgr5 e métodos de uso do mesmo
IT1397181B1 (it) Componente micromeccanico
BRPI0921992A2 (pt) moduladores tgr5 e métodos de uso destes
ZA201008483B (en) Diazacarbazoles and methods of use
EP2294227A4 (en) CONCENTRATION TEST
EP2349335A4 (en) LEVETIRACETAM IMMUNOASSAYS
BRPI0909289A2 (pt) Mistura simbiótica
BRPI0814876A2 (pt) Análogos de pirona fosforilados e métodos
BRPI0813681A2 (pt) Detecção de coproantígeno de nematelminto
BRPI0922150A2 (pt) dispositivo de iluminação e dispositivo de vídeo
DK2387466T3 (da) Dekantercentrifuge og dekantercentrifuge-udledningsåbningselement
IL209548A0 (en) Diazacarbazoles and methods of use
EP2321966A4 (en) BRIGHTNESS EVALUATION
DK2325662T3 (da) Multi-indlæsnings- og multi-udlæsningsanalysator
ZA201006932B (en) Modulators of dopamine neurotransmission
IT1397180B1 (it) Componente micromeccanico
FI20080112A0 (fi) Seos
ZA201007010B (en) Rapid detection of mycobateria
IL205044A0 (en) Amide linked modulators of ?? - secretase

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A61K 38/47 (2006.01), A23J 3/34 (2006.01), A23L 33

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23J 3/34 (2006.01), C12P 13/22 (2006.01), C12P 21

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/02/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/04/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF